Boothbay Fund Management, LLC Sage Therapeutics, Inc. Call Options Transaction History

Boothbay Fund Management, LLC

  • $3.6 Billion
  • Q3 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$10.58 - $17.9 $5.01 Million - $8.48 Million
473,500 New
473,500 $5.14 Million
Q1 2022

May 16, 2022
BUY
$30.71 - $45.71 $942,797 - $1.4 Million
30,700 New
30,700 $1.02 Million
Q3 2021

Nov 15, 2021
SELL
$40.26 - $57.37 $1.16 Million - $1.65 Million
-28,700 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$54.88 - $79.29 $1.58 Million - $2.28 Million
28,700 New
28,700 $1.63 Million

Others Institutions Holding SAGE

# of Institutions
218
Shares Held
46.4M
Call Options Held
847K
Put Options Held
188K
View Full List

About Sage Therapeutics, Inc.

SAGE Quotes by TradingView
  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $340M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email